Linezolid Accord

Linezolid, the active ingredient in Linezolid Accord, is a oxazolidinone antibiotic presented as an oral dosage form for systemic use. It treats serious Gram‑positive bacterial infections, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE), in adult patients.

GNH USA supplies Linezolid Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Linezolid is an oxazolidinone antibiotic used to treat infections caused by Gram‑positive bacteria.

- Gram‑positive bacterial infections: effective against infections caused by susceptible Gram‑positive organisms. - Methicillin‑resistant Staphylococcus aureus (MRSA): treats skin, soft‑tissue and respiratory infections due to MRSA. - Vancomycin‑resistant Enterococcus (VRE): provides an option for infections caused by VRE strains.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools that may be watery. - Headache: transient cranial discomfort. - Metallic taste: altered taste sensation in the mouth.

Serious or Rare Side Effects: - Thrombocytopenia: significant reduction in platelet count. - Peripheral neuropathy: numbness or tingling in extremities. - Serotonin syndrome: potentially life‑threatening reaction when combined with serotonergic agents. - Severe allergic reaction: includes anaphylaxis and angioedema.

Before prescribing Linezolid, clinicians should consider several safety factors. - Renal impairment: dose adjustment may be required in patients with reduced kidney function. - Hepatic impairment: monitor liver enzymes and adjust therapy as needed. - Concomitant serotonergic drugs: avoid or closely monitor for serotonin syndrome. - Hematologic monitoring: regular blood counts to detect thrombocytopenia or anemia. - Pregnancy and breastfeeding: safety not established; use only if benefits outweigh potential risks. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Linezolid can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Serotonergic agents (SSRIs, SNRIs, tricyclic antidepressants): may precipitate serotonin syndrome. - Rifampin: induces metabolism, reducing linezolid exposure.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR and bleeding risk. - NSAIDs: additive effect on bleeding tendency. - Anticonvulsants (e.g., phenytoin): may lower linezolid plasma levels.